Latest filing published 29 Jan 2019 for Gentian Diagnostics ASA, €980k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +5.4%Entry NOK 56.00 · Close at T+365 NOK 59.00
- -24.4%Entry NOK 62.00 · Close at T+365 NOK 46.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Henrik Krefting: trading record in brief
All filings by Henrik Krefting on record concern Gentian Diagnostics ASA. Over a trading history stretching from 3 October 2018 to 29 January 2019, the count stands at 2 filings.
Every open-market trade on record is a purchase: 2 purchases worth €1.8M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2019 to date brings 1 purchase and no sales.
On 29 January 2019 came the latest disclosure, an open-market purchase for €980k in Gentian Diagnostics ASA. Source: insider filings from Oslo Børs. Past trades are no guide to future returns.
Companies and markets linked to Henrik Krefting
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 175,000 shares@ NOK 54.50ShareMERKOSLO:468258Canonical exit: 29 Apr 2019 (T+90)
- 135,526 shares@ NOK 59.14ShareMERKOSLO:460597Canonical exit: 1 Jan 2019 (T+90)
2 of 2 declarations